Korea Bio-Gen Co.Ltd (318000) — Net Asset Momentum
Korea Bio-Gen Co.Ltd (318000) recorded a net asset momentum of 4.5% as of December 2025, with net assets of ₩46.93 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Korea Bio-Gen Co.Ltd (318000) tangible net worth to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Korea Bio-Gen Co.Ltd Net Asset Momentum (2017–2025)
This chart tracks Korea Bio-Gen Co.Ltd's year-over-year net asset growth across 9 annual reporting periods from 2017 to 2025. The most recent momentum reading is +4.5%, with net assets of ₩46.93 Billion KRW as of December 2025. Read Korea Bio-Gen Co.Ltd (318000) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Korea Bio-Gen Co.Ltd (2017–2025)
The table below shows the complete annual net asset history for Korea Bio-Gen Co.Ltd from 2017 to 2025, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 318000 market cap.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩46.93 Billion | ₩52.35 Billion | ₩5.42 Billion | ▲ +4.5% |
| 2024 | ₩44.91 Billion | ₩51.64 Billion | ₩6.73 Billion | ▲ +6.8% |
| 2023 | ₩42.05 Billion | ₩45.95 Billion | ₩3.90 Billion | ▲ +20.3% |
| 2022 | ₩34.95 Billion | ₩43.07 Billion | ₩8.13 Billion | ▲ +10.6% |
| 2021 | ₩31.61 Billion | ₩42.00 Billion | ₩10.39 Billion | ▲ +12.2% |
| 2020 | ₩28.16 Billion | ₩31.07 Billion | ₩2.91 Billion | ▲ +9.6% |
| 2019 | ₩25.69 Billion | ₩28.16 Billion | ₩2.47 Billion | ▲ +134.1% |
| 2018 | ₩10.97 Billion | ₩19.80 Billion | ₩8.83 Billion | ▲ +22.9% |
| 2017 | ₩8.93 Billion | ₩16.80 Billion | ₩7.88 Billion | — |